BioRad Laboratories (BIO)
(Delayed Data from NYSE)
$301.92 USD
+5.10 (1.72%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $302.11 +0.19 (0.06%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum D VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Top 30% (76 out of 250)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.25 | 1.69 | 9.99 |
Current Quarter Estimate | 2.12 | 5.88 | 61.00 |
Year Ago Quarter Estimate | 3.00 | 4.88 | 54.84 |
Next Quarter Estimate | 2.84 | 7.06 | 63.00 |
Next Year Estimate | 11.75 | 39.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -8.32 | 11.70 | 15.67 |
Next Year | 8.80 | 26.30 | 9.31 |
Last 5 Years | 15.60 | 3.90 | 8.10 |
Next 5 Years | NA | 14.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 27.69 | -13.85 |
Price/Book (MRQ) | 0.94 | 1.97 |
Price/Cash Flow (MRFY) | 24.52 | 10.91 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -12.37% | -7.07% |
Return on Equity (TTM) | 3.59% | 6.21% |
Debt to Equity (MRQ) | NA | 17.49 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.